OrthoPediatrics Corp.

NASDAQ:KIDS

Medical - Devices

Healthcare
$31.65 +1.05%

+$0.19 today

Market cap
$826.40M
Beta
1.01
P/E (TTM)
-11.0
EPS (TTM)
-$1.68
52W Low $14.42High $23.70

Volume 0.16M

Average 0.16M

KIDS Inventory

Cash effect of the change in inventory; building inventory consumes cash.

OrthoPediatrics Corp.NASDAQ: KIDS

Inventory · Q1 FY2026 · quarter ended Mar 2026

Inventory turns positive

Q1 FY2026 inventory was $139K, compared with -$1.91M a year earlier. Trailing-twelve-month inventory was -$6.42M. Over 3 fiscal years it compounded at -20.6% a year.

Context

  • Inventory amounted to 3.6% of revenue in FY2025, down 2.9 pp from a year earlier.
  • Inventory grew in size in 1 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly inventory holds near $139K or moves back toward the trailing-twelve-month quarterly average of -$1.61M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$139K+124.1% QoQ
Last fiscal yearDec 2025
-$8.47M-35.8% YoY
LTMMar 2026
-$6.42M-24.2% YoY
Inventory past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+107.3%——
1 year-35.8%——
3-year CAGR-20.6%——
5-year CAGR——
10-year CAGR——

Inventory history

USD · from the cash flow

Latest · FY2025
(8.47M) USD
Year-over-year change
+35.8%

Inventory vs competitors

How KIDS compares with its peers on the latest reported figures

  • KIDS's LTM Mar 2026 inventory of $6.42M is the 5th largest of the 8 companies compared; the peer median is $348K.
  • Its year-over-year change of -24.2% is the 7th highest of 8, against a peer median of +154.8%.
  • Inventory amounts to 2.6% of revenue for KIDS, versus a peer median of 2.2%.
KIDS Competitors Peer median
Inventory for KIDS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
RXSTRxSight, Inc.LTM Mar 2026$13.26M +154.9%+15.0%10.4%
TOIThe Oncology Institute, Inc.LTM Mar 2026$11.98M +1489.1%+58.0%2.2%
EOLSEvolus, Inc.LTM Mar 2026$8.8M -541.3%+1.3%2.9%
BVSBioventus Inc.LTM Mar 2026$7.8M +154.8%—1.4%
KIDSOrthoPediatrics Corp.LTM Mar 2026$6.42M -24.2%-20.6%2.6%
LABStandard BioTools Inc.LTM Mar 2026$2.78M +137.7%+10.8%3.2%
TMCITreace Medical Concepts, Inc.LTM Mar 2026$1.57M +175.7%—0.8%
CBLLCeriBell, Inc.LTM Mar 2026$348K +1.2%-43.1%0.4%
Peer median (excluding KIDS) $348K+154.8%+10.8%2.2%

Competitors are the stored peer set for KIDS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(16.26M)1.26M(20.97M)(37.82M)(39.65M)
Depreciation & Amortization10.68M13.1M17.39M19.08M21.12M
Deferred Income Tax(1.13M)(5.03M)(1.16M)(4.74M)(153K)
Stock-Based Compensation5.84M6.68M10.53M13.55M17.78M
Change in Working Capital(12.55M)(17.76M)(32.2M)(22.94M)(10.79M)
Accounts Receivables(466K)(3.98M)(9.72M)(4.75M)(9.37M)
Inventory(5.05M)(16.94M)(26.28M)(13.2M)(8.47M)
Accounts Payables(567K)(209K)1.49M(4.28M)8.17M
Other Working Capital(6.47M)3.37M2.32M(709K)(1.12M)
Other Non-Cash Items354K(20.01M)(623K)5.82M6.85M
Operating Cash Flow(13.06M)(21.77M)(27.05M)(27.05M)(4.85M)
Capital Expenditures(16.01M)(10.03M)(18.98M)(14.26M)(11.11M)
Acquisitions (Net)0(40.09M)(3.64M)(20.23M)(15.5M)
Purchases of Investments0(110.12M)(48.6M)(25.65M)(17.02M)
Sales of Investments9.25M46.87M112.9M49.86M0
Other Investing Activities(650K)0(2.11M)(2.88M)0
Investing Cash Flow(7.41M)(113.37M)41.68M(13.16M)(43.63M)
Debt Repayment(131K)(137K)9.28M56.54M23.98M
Common Stock Issued137K139.28M21K00
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities0(3.17M)(2M)(3.41M)0
Financing Cash Flow6K135.97M7.3M53.14M23.98M
Effect of Forex Changes(658K)619K633K(175K)348K
Net Change in Cash(21.13M)1.46M22.57M12.75M(24.16M)
Free Cash Flow(29.07M)(31.8M)(46.03M)(41.31M)(15.96M)

OrthoPediatrics Corp.

NASDAQ:KIDS

Intrinsic Alpha fair value

Locked

Current Price

$31.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.